Hantavirus
Scientists at University of Helsinki detail research in hantavirus
Published in Medical Letter on the CDC and FDA, January 31st, 2010
"Here, we show that the cytoplasmic tails of the glycoproteins of the apathogenic hantaviruses Tula virus (TULV) and PHV are also degraded through the ubiquitin-proteasome pathway, both in human HEK-293 and in simian Vero E6 cells. TULV Gn tails formed aggresomes in cells with proteasomal inhibitors," wrote H. Wang and colleagues, University of Helsinki.
The researchers concluded: "Degradation...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- American Association for Cancer Research
Gene testing identifies lung cancer patients who benefit from ALK-inhibitor drug - New York- Presbyterian Hospital/Weill Cornell Medical Center/Weill Cornell Medical College
Reducing dosage of Parkinson's drugs can cause symptoms similar to those of cocaine withdrawal - Absorption Systems
Study Shows the Unique Power of Absorption Systems' CellPort Technologies(TM) - Blue Spoon Consulting Group, LLC
Blue Spoon Publishes Industry Strategy for FDA's Sentinel Initiative - Cervical Intraepithelial Neoplasia
Studies from S. Tiews and co-researchers update current data on cervical intraepithelial neoplasia - Drug Development
Studies from J.J.P. Schimmel et al add new findings in the area of drug development - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
